LEAH MELTON: Open Payments
NPI 1679824601 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$32,439 in 91 payments from 14 companies in 2025. Trend: 2023 $13,051 · 2024 $14,559 · 2025 $32,439
Speaker / faculty: $22,488Honoraria: $5,075Travel & lodging: $2,561Food & beverage: $2,315
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 34 | $24,713 |
| Xeris Pharmaceuticals, Inc. | 19 | $6,020 |
| Tandem Diabetes Care, Inc. | 8 | $1,114 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $167 |
| Mannkind Corporation | 3 | $97 |
| BETA BIONICS, INC. | 4 | $84 |
| Corcept Therapeutics | 2 | $53 |
| Sequel Med Tech, LLC | 2 | $42 |
| CeQur Corporation | 1 | $35 |
| Insulet Corporation | 2 | $35 |
Products named: Ozempic, GVOKE HYPOPEN, t:slim X2 Insulin Pump with Control-IQ, JARDIANCE, AFREZZA, iLet Bionic Pancreas, Korlym, TWIIST.
Industry payments across OK — which companies pay providers there.
